Skip to content
Choice Online

The Zimbabwean Government Declines ‘Lopsided’ US Health Aid Agreement Due to Data Apprehensions

Medical funding image
The offered American funding was aimed at initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has rejected a substantial American healthcare agreement worth $367m (272 million pounds) spanning five years due to the United States' insistence on confidential information.

This move was revealed following a government memo from December was disclosed, revealing that President Emmerson Mnangagwa felt the deal was "skewed".

A government spokesperson later explained that the United States was demanding access to health data for scientific study and profit but refused to share the resulting advantages from future treatments.

"We are forced to start the challenging and unfortunate process of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy noted the US had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A medical body in Zimbabwe has appealed for further negotiations to reach a deal agreeable to all parties so the nation's vital HIV programme can proceed.

Wider Implications

This development comes after a comparable case in neighbouring Kenya, where a court halted a related health funding agreement after concerns were filed about the safety of citizens' health data.

Since returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

The agency had overseen assistance for the American government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost openness and responsibility.

According to statements, Sixteen nations in Africa have so far signed similar agreements, constituting more than $18.3bn in new funding.

Details of the Declined Agreement

This assistance for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this cooperation could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million presently on HIV treatment via American-funded initiatives," the Ambassador said.

However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".

"Zimbabwe was being asked to provide its genetic material and health information over an extended period, without any equivalent assurance of benefiting from any medical innovations – like new medicines or tests – that might result from that shared data," Mangwana explained.

"Put simply, our country would supply the raw materials for medical research without any certainty that the end products would be available to our people if a future disease outbreak emerge."

National Interest and Global Health

He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining frameworks already established via the global organization.

The spokesperson cited its Pandemic Benefit-Sharing framework created to manage future global health emergencies.

"This framework is designed to guarantee that when a country contributes its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."

The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We encourage continued discussions with our American counterparts on how future collaboration might be designed in a manner that honours the independence and interests of both nations."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but suggested that talks should continue since much of the country's Aids initiatives were funded by foreign aid.

"In cases where technical issues exist, such as those relating to data governance or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," the group added.

The situation underscores the ongoing tensions between receiving much-needed international aid and protecting national sovereignty in an ever more data-driven world.

HW
About the author

Hayley Walker

A seasoned consumer rights activist and digital strategist with over a decade of experience in market research.

Choice Online

Type to search articles.